| Q95359340 | Q95359340 |
| Q36905958 | 2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary |
| Q30620088 | A novel comparative effectiveness study of Tai Chi versus aerobic exercise for fibromyalgia: study protocol for a randomized controlled trial |
| Q35128498 | A practical approach to fibromyalgia |
| Q38471736 | A randomized controlled trial of 8-form Tai chi improves symptoms and functional mobility in fibromyalgia patients |
| Q34136290 | A randomized trial of tai chi for fibromyalgia |
| Q24244688 | Anti-depressants and centrally active agents for fibromyalgia syndrome |
| Q24197464 | Anticonvulsants for fibromyalgia |
| Q30500822 | Biology and therapy of fibromyalgia. Functional magnetic resonance imaging findings in fibromyalgia |
| Q24684137 | Biology and therapy of fibromyalgia. New therapies in fibromyalgia |
| Q36088604 | Characteristics and healthcare costs of patients with fibromyalgia syndrome |
| Q35172571 | Chronic diffuse musculoskeletal pain, fibromyalgia and co-morbid unexplained clinical conditions |
| Q82343465 | Chronic pelvic pain: epidemiology and economic impact |
| Q36949789 | Cognitive behavioral therapy for the treatment of juvenile fibromyalgia: a multisite, single-blind, randomized, controlled clinical trial |
| Q24198161 | Cognitive behavioural therapies for fibromyalgia |
| Q24200637 | Cognitive behavioural therapies for fibromyalgia syndrome |
| Q57565891 | Comorbid clinical conditions in chronic fatigue |
| Q24550607 | Comorbid clinical conditions in chronic fatigue: a co-twin control study |
| Q48415141 | Comparing fibromyalgia patients from primary care and rheumatology settings: clinical and psychosocial features. |
| Q37198557 | Comparison of economic impact of chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis/painful bladder syndrome |
| Q36641534 | Cost-utility of an 8-month aquatic training for women with fibromyalgia: a randomized controlled trial |
| Q36302431 | Costs in rheumatology: results and lessons learned from the 'Hannover Costing Study'. |
| Q34394421 | Cross-cultural adaptation and validation of a Bengali version of the modified fibromyalgia impact questionnaire. |
| Q33334488 | Definition, classification and diagnosis of fibromyalgia syndrome |
| Q36926826 | Describing the characteristics, treatment pathways, outcomes, and costs of people with persistent noncancer pain managed by community pain clinics and generating an indicative estimate of cost-effectiveness: feasibility study protocol |
| Q74289919 | Disability evaluation of fibromyalgia |
| Q51760812 | Effect of tai chi versus aerobic exercise for fibromyalgia: comparative effectiveness randomized controlled trial. |
| Q33794327 | Effects of Vitamin D Therapy on Quality of Life in Patients with Fibromyalgia |
| Q37549342 | Evaluating Evidence for the Role of Sleep in Fibromyalgia: A Test of the Sleep and Pain Diathesis Model |
| Q74763222 | Evaluation of a patient-centred approach in generalized musculoskeletal chronic pain/fibromyalgia patients in primary care |
| Q48413066 | Exercise-based motivational interviewing for female patients with fibromyalgia: a case series |
| Q34207472 | Fibromyalgia and other unexplained clinical conditions |
| Q50859746 | Fibromyalgia in Indian patients with SLE. |
| Q35063775 | Fibromyalgia patients have reduced hippocampal volume compared with healthy controls |
| Q24806243 | Fibromyalgia syndrome improved using a mostly raw vegetarian diet: an observational study |
| Q37103587 | Fibromyalgia syndrome: presentation, diagnosis, differential diagnosis, and vulnerability. |
| Q35991527 | Fibromyalgia-related costs and loss of productivity: a substantial societal burden |
| Q34009681 | Fibromyalgia: From treatment to rehabilitation |
| Q38185990 | Fibromyalgia: disease synopsis, medication cost effectiveness and economic burden |
| Q37902512 | Fibromyalgia: from pathophysiology to therapy |
| Q51096838 | Fibromyalgia: more questions and implications. |
| Q35729778 | Fibromyalgia: revisiting the literature. |
| Q37313483 | Fibromyalgia: should the treatment paradigm be monotherapy or combination pharmacotherapy? |
| Q52613768 | Gender Differences in the Prevalence of Fibromyalgia and in Concomitant Medical and Psychiatric Disorders: A National Veterans Health Administration Study. |
| Q35136682 | Geographic variation of chronic opioid use in fibromyalgia |
| Q36797580 | Health-resource use and costs associated with fibromyalgia in France, Germany, and the United States |
| Q36488214 | In search of pharmacoeconomic evaluations for fibromyalgia treatments: a review |
| Q33951946 | Intravenous micronutrient therapy (Myers' Cocktail) for fibromyalgia: a placebo-controlled pilot study |
| Q34011229 | Is fibromyalgia a distinct clinical syndrome? |
| Q54702216 | Is there a new finding added to the fibromyalgia syndrome? |
| Q33973136 | Is there an association between fibromyalgia and an increase in comorbidity: neoplastic and cardiovascular diseases, infections and mortality? |
| Q35555306 | Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis |
| Q36407500 | Lifestyle-oriented non-pharmacological treatments for fibromyalgia: a clinical overview and applications with home-based technologies |
| Q73065103 | Listening to the patient: a practical guide to self-report questionnaires in clinical care |
| Q44903736 | Lyme disease--what is the cost for Scotland? |
| Q33493086 | Management of fibromyalgia syndrome--an interdisciplinary evidence-based guideline |
| Q24200385 | Monoamine oxidase inhibitors (MAOIs) for fibromyalgia syndrome |
| Q38027051 | Monotherapy or combination therapy for fibromyalgia treatment? |
| Q24245928 | NSAIDs, analgesics and opioids agents for fibromyalgia syndrome |
| Q75828569 | Nerve conduction tests in patients with fibromyalgia syndrome |
| Q35157516 | Non-invasive brain stimulation approaches to fibromyalgia pain |
| Q36116420 | Patients with fibromyalgia display less functional connectivity in the brain's pain inhibitory network |
| Q34280026 | Pharmacologic treatment of fibromyalgia |
| Q35172581 | Pharmacological therapies in fibromyalgia |
| Q58160879 | Predictors of health status in women with fibromyalgia: A prospective study |
| Q48469708 | Prevalence of temporomandibular disorders in fibromyalgia and failed back syndrome patients: a blinded prospective comparison study |
| Q36060887 | Psychiatric comorbidity in fibromyalgia |
| Q34011224 | Psychological determinants of fibromyalgia and related syndromes |
| Q45978394 | Quality of life in patients with ankylosing spondylitis. |
| Q53314885 | Quantifying pain threshold and quality of life of fibromyalgia patients. |
| Q34746409 | Rational and targeted pharmacologic treatment of fibromyalgia |
| Q37478527 | Real-world comparison of health care utilization between duloxetine and pregabalin initiators with fibromyalgia |
| Q37676178 | Reliability and validity of the Turkish version of the fibromyalgia rapid screening tool (FiRST) |
| Q36834489 | Resource utilisation and direct costs in patients with recently diagnosed fibromyalgia who are offered one of three different interventions in a randomised pragmatic trial |
| Q64083829 | Retracted: A parallel randomized controlled trial examining the effects of rhythmic sensory stimulation on fibromyalgia symptoms |
| Q37691161 | Review of pharmacological therapies in fibromyalgia syndrome |
| Q33469649 | Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials |
| Q24201799 | Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome |
| Q37807699 | Sleep, pain, fibromyalgia, and chronic fatigue syndrome |
| Q37575438 | Societal and patient burden of fibromyalgia syndrome |
| Q37003514 | Tender point count, pain, and mobility in the older population: the mobilize Boston study |
| Q26801572 | The Iceberg Nature of Fibromyalgia Burden: The Clinical and Economic Aspects |
| Q34158713 | The association between incident self-reported fibromyalgia and nonpsychiatric factors: 25-years follow-up of the Adventist Health Study |
| Q30417956 | The effect of low-frequency sound stimulation on patients with fibromyalgia: a clinical study |
| Q37264998 | The feasibility and efficacy of a multidisciplinary intervention with aftercare meetings for fibromyalgia |
| Q33967469 | The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). |
| Q34263924 | The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis |
| Q37980516 | The role of antipsychotics in the management of fibromyalgia |
| Q34197902 | Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study |
| Q33857189 | Trauma and fibromyalgia: is there an association and what does it mean? |
| Q21257175 | Trazodone for the treatment of fibromyalgia: an open-label, 12-week study |
| Q33901469 | Trazodone plus pregabalin combination in the treatment of fibromyalgia: a two-phase, 24-week, open-label uncontrolled study |
| Q37206982 | Treating patients with fibromyalgia in primary care settings under routine medical practice: a claim database cost and burden of illness study |
| Q35754445 | Use of complementary and alternative medicine providers by fibromyalgia patients under insurance coverage |
| Q30621023 | Use of neuroimaging to understand abnormal pain sensitivity in fibromyalgia |
| Q47676478 | WITHDRAWN: Anticonvulsants for fibromyalgia. |
| Q28083120 | What has functional connectivity and chemical neuroimaging in fibromyalgia taught us about the mechanisms and management of 'centralized' pain? |
| Q84600245 | [A bibliometric approach to research into fibromyalgia] |
| Q52969293 | [Conceptual and methodological basics of cost assessments in rheumatology]. |
| Q74243876 | [Consensus report on the diagnosis and treatment of fibromyalgia in Catalonia] |
| Q73283477 | [Fibromyalgia: a Cinderella diagnosis] |
| Q52089575 | [Neuroendocrine changes and maladaptations in fibromyalgia. Etiopathogenetic findings]. |
| Q74430434 | [Study of quality of life of patients with fibromyalgia: impact of a health education programme] |